T1	Participants 850 940	patients with myeloid leukemia undergoing allogeneic stem cell transplantation (allo-SCT).
T2	Participants 1323 1341	Fifty-one patients
T3	Participants 1406 1906	There were 32 males and 19 females, with a median age of 45 years (range: 6-59). Nine patients had chronic myeloid leukemia (CML) (BC: 2, second AP: 3, and tyrosine-kinase inhibitor refractory first chronic phase [CP]: 4). Forty-two patients had AML: 14 were induction failures, 8 in first chemotherapy-refractory relapse, 7 in untreated relapse, 3 in second or subsequent relapse, 4 were in second complete remission (CR), and 3 in second CR without platelet recovery (CRp), 2 were in high-risk CR1.
T4	Participants 2164 2229	Forty-one patients had active leukemia at the time of transplant,